Literature DB >> 12446780

Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence.

Alberto Inga1, Francesca Storici, Thomas A Darden, Michael A Resnick.   

Abstract

Little is known about the mechanisms that regulate differential transactivation by p53. We developed a system in the yeast Saccharomyces cerevisiae that addresses p53 transactivation capacity from 26 different p53 response elements (REs) under conditions where all other factors, such as chromatin, are kept constant. The system relies on a tightly regulated promoter (rheostatable) that can provide for a broad range of p53 expression. The p53 transactivation capacity toward each 20- to 22-bp-long RE could be ranked by using a simple phenotypic assay. Surprisingly, there was as much as a 1,000-fold difference in transactivation. There was no correlation between the functional rank and statistical predictions of binding energy of the REs. Instead we found that the central sequence element in an RE greatly affects p53 transactivation capacity, possibly because of DNA structural properties. Our results suggest that intrinsic DNA binding affinity and p53 protein levels are important contributors to p53-induced differential transactivation. These results are also relevant to understanding the regulation by other families of transcription factors that recognize several sequence-related response elements and/or have tightly regulated expression. We found that p53 had weak activity towards half the apoptotic REs. In addition, p53 alleles associated with familial breast cancer, previously classified as wild type, showed subtle differences in transactivation capacity towards several REs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12446780      PMCID: PMC139870          DOI: 10.1128/MCB.22.24.8612-8625.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  89 in total

1.  DNA damage induced p53 stabilization: no indication for an involvement of p53 phosphorylation.

Authors:  C Blattner; E Tobiasch; M Litfen; H J Rahmsdorf; P Herrlich
Journal:  Oncogene       Date:  1999-03-04       Impact factor: 9.867

2.  ASPP proteins specifically stimulate the apoptotic function of p53.

Authors:  Y Samuels-Lev; D J O'Connor; D Bergamaschi; G Trigiante; J K Hsieh; S Zhong; I Campargue; L Naumovski; T Crook; X Lu
Journal:  Mol Cell       Date:  2001-10       Impact factor: 17.970

3.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.

Authors:  M D Kaeser; R D Iggo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

4.  Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels.

Authors:  D Ronen; D Schwartz; Y Teitz; N Goldfinger; V Rotter
Journal:  Cell Growth Differ       Date:  1996-01

5.  Prognostic significance of p53 mutation in breast cancer: frequent detection of non-missense mutations by yeast functional assay.

Authors:  P O Chappuis; A Estreicher; B Dieterich; H Bonnefoi; M Otter; A P Sappino; R Iggo
Journal:  Int J Cancer       Date:  1999-12-22       Impact factor: 7.396

6.  Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.

Authors:  A Inga; M A Resnick
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

7.  p53-dependent expression of PIG3 during proliferation, genotoxic stress, and reversible growth arrest.

Authors:  P M Flatt; K Polyak; L J Tang; C D Scatena; M D Westfall; L A Rubinstein; J Yu; K W Kinzler; B Vogelstein; D E Hill; J A Pietenpol
Journal:  Cancer Lett       Date:  2000-08-01       Impact factor: 8.679

8.  Regulation of p53 activity in nuclear bodies by a specific PML isoform.

Authors:  V Fogal; M Gostissa; P Sandy; P Zacchi; T Sternsdorf; K Jensen; P P Pandolfi; H Will; C Schneider; G Del Sal
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

9.  Structure-based rescue of common tumor-derived p53 mutants.

Authors:  A M Wieczorek; J L Waterman; M J Waterman; T D Halazonetis
Journal:  Nat Med       Date:  1996-10       Impact factor: 53.440

10.  14-3-3sigma is a p53-regulated inhibitor of G2/M progression.

Authors:  H Hermeking; C Lengauer; K Polyak; T C He; L Zhang; S Thiagalingam; K W Kinzler; B Vogelstein
Journal:  Mol Cell       Date:  1997-12       Impact factor: 17.970

View more
  84 in total

1.  Functional mutants of the sequence-specific transcription factor p53 and implications for master genes of diversity.

Authors:  Michael A Resnick; Alberto Inga
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-08       Impact factor: 11.205

2.  Transcription factor oscillations induce differential gene expressions.

Authors:  Keng Boon Wee; Wee Kheng Yio; Uttam Surana; Keng Hwee Chiam
Journal:  Biophys J       Date:  2012-06-05       Impact factor: 4.033

3.  Differential recognition of response elements determines target gene specificity for p53 and p63.

Authors:  Motonobu Osada; Hannah Lui Park; Yuichi Nagakawa; Keishi Yamashita; Alexey Fomenkov; Myoung Sook Kim; Guojun Wu; Shuji Nomoto; Barry Trink; David Sidransky
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  A p53-type response element in the GDF15 promoter confers high specificity for p53 activation.

Authors:  Motonobu Osada; Hannah Lui Park; Min Joo Park; Jun-Wei Liu; Guojun Wu; Barry Trink; David Sidransky
Journal:  Biochem Biophys Res Commun       Date:  2007-01-25       Impact factor: 3.575

5.  A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage.

Authors:  Jun Yan; Daniel Menendez; Xiao-Ping Yang; Michael A Resnick; Anton M Jetten
Journal:  J Biol Chem       Date:  2009-05-11       Impact factor: 5.157

Review 6.  Another fork in the road--life or death decisions by the tumour suppressor p53.

Authors:  Luis A Carvajal; James J Manfredi
Journal:  EMBO Rep       Date:  2013-04-16       Impact factor: 8.807

Review 7.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

8.  Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-04       Impact factor: 11.205

Review 9.  Lessons learned from next-generation sequencing in head and neck cancer.

Authors:  Myriam Loyo; Ryan J Li; Chetan Bettegowda; Curtis R Pickering; Mitchell J Frederick; Jeffrey N Myers; Nishant Agrawal
Journal:  Head Neck       Date:  2012-08-21       Impact factor: 3.147

Review 10.  Versatile functions of p53 protein in multicellular organisms.

Authors:  P M Chumakov
Journal:  Biochemistry (Mosc)       Date:  2007-12       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.